What we heard: Agile regulations for advanced therapeutic products and clinical trials (English, HTML)
View metadata and access the original English HTML file: What we heard: Agile regulations for advanced therapeutic products and clinical trials.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2022-06-07
The Health and Biosciences Sector Regulatory Review Roadmap outlined a number of regulatory modernization commitments. These included plans to modernize the regulations for clinical trials and advanced therapeutic products (ATPs).
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file